Literature DB >> 32157769

Community education to enhance the more equitable use of precision medicine in Northern Manhattan.

Grace C Hillyer1,2, Karen M Schmitt2,3, Andria Reyes2, Alejandro Cruz2, Maria Lizardo4, Gary K Schwartz2,5, Mary Beth Terry1,2.   

Abstract

Focusing screening and treatment to those most likely to benefit is the promise of precision medicine but inequitable distribution of precision medicine innovations may exacerbate health disparities. We investigated whether complex genomic concepts can be successfully communicated to diverse populations. Incorporating principles of Community-based Participatory Research, we created a precision medicine curriculum tailored to the needs of our predominantly Hispanic community. We administered the curriculum over 26 months, assessed pre- and post-test comprehension of 8 genetics-related terms, and compared comprehension differences based on demography and health literacy. In total, 438 individuals completed pre-/post-test assessments. At pre-test, 45.6% scored ≥75% across eight major constructs; 66.7% at post-test. Comprehension increased for 7/8 terms with greatest pre/post-test increases for 'mutation' (55% to 78%) and 'sporadic' (34% to 59%). Mean pre-test comprehension scores (≥75%) were lower for Spanish versus. English speakers; mean post-test scores were equivalent. No heterogeneity by demographics or health literacy was observed. We demonstrate that a brief community educational program can improve knowledge of complex genomic concepts. Interventions to increase understanding of genomic concepts underlying precision medicine are key to patients making informed treatment and prevention decisions and may lead to more equitable uptake of precision medicine initiatives.
© 2020 National Society of Genetic Counselors.

Entities:  

Keywords:  community; community-based participatory research; comprehension; disparities; diversity; education; health education; hispanic; intervention; precision medicine; public health; underrepresented populations

Mesh:

Year:  2020        PMID: 32157769      PMCID: PMC7138137          DOI: 10.1002/jgc4.1244

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

1.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.

Authors:  Ian Krop; Nofisat Ismaila; Fabrice Andre; Robert C Bast; William Barlow; Deborah E Collyar; M Elizabeth Hammond; Nicole M Kuderer; Minetta C Liu; Robert G Mennel; Catherine Van Poznak; Antonio C Wolff; Vered Stearns
Journal:  J Clin Oncol       Date:  2017-07-10       Impact factor: 44.544

2.  Correlates of Dominicans' Identification of Cancer as a Worrisome Health Problem.

Authors:  Alsacia L Sepulveda-Pacsi; Suzanne Bakken
Journal:  J Immigr Minor Health       Date:  2017-10

Review 3.  Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.

Authors:  Yiwey Shieh; Martin Eklund; Lisa Madlensky; Sarah D Sawyer; Carlie K Thompson; Allison Stover Fiscalini; Elad Ziv; Laura J Van't Veer; Laura J Esserman; Jeffrey A Tice
Journal:  J Natl Cancer Inst       Date:  2017-01-27       Impact factor: 13.506

Review 4.  Targeted Cancer Screening in Average-Risk Individuals.

Authors:  Pamela M Marcus; Andrew N Freedman; Muin J Khoury
Journal:  Am J Prev Med       Date:  2015-07-10       Impact factor: 5.043

5.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Authors:  Timothy R Rebbeck; Henry T Lynch; Susan L Neuhausen; Steven A Narod; Laura Van't Veer; Judy E Garber; Gareth Evans; Claudine Isaacs; Mary B Daly; Ellen Matloff; Olufunmilayo I Olopade; Barbara L Weber
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

6.  Electronic Communication Channel Use and Health Information Source Preferences Among Latinos in Northern Manhattan.

Authors:  Grace Clarke Hillyer; Karen M Schmitt; Maria Lizardo; Andria Reyes; Mercedes Bazan; Maria C Alvarez; Rossy Sandoval; Kazeem Abdul; Manuela A Orjuela
Journal:  J Community Health       Date:  2017-04

7.  Genetic Testing Awareness and Attitudes among Latinos: Exploring Shared Perceptions and Gender-Based Differences.

Authors:  Jada G Hamilton; Elyse Shuk; Guedy Arniella; C Javier González; Geoffrey S Gold; Francesca Gany; Mark E Robson; Jennifer L Hay
Journal:  Public Health Genomics       Date:  2015-11-11       Impact factor: 2.000

8.  Survey of US public attitudes toward pharmacogenetic testing.

Authors:  S B Haga; J M O'Daniel; G M Tindall; I R Lipkus; R Agans
Journal:  Pharmacogenomics J       Date:  2011-02-15       Impact factor: 3.550

Review 9.  Communication about genetic testing with breast and ovarian cancer patients: a scoping review.

Authors:  Chris Jacobs; Christine Patch; Susan Michie
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

10.  Aspirin use and risk of colorectal cancer according to BRAF mutation status.

Authors:  Reiko Nishihara; Paul Lochhead; Aya Kuchiba; Seungyoun Jung; Mai Yamauchi; Xiaoyun Liao; Yu Imamura; Zhi Rong Qian; Teppei Morikawa; Molin Wang; Donna Spiegelman; Eunyoung Cho; Edward Giovannucci; Charles S Fuchs; Andrew T Chan; Shuji Ogino
Journal:  JAMA       Date:  2013-06-26       Impact factor: 56.272

View more
  2 in total

Review 1.  Challenges and Future Prospects of Precision Medicine in Psychiatry.

Authors:  Mirko Manchia; Claudia Pisanu; Alessio Squassina; Bernardo Carpiniello
Journal:  Pharmgenomics Pers Med       Date:  2020-04-23

2.  The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children.

Authors:  Jacqueline A Odgis; Katie M Gallagher; Sabrina A Suckiel; Katherine E Donohue; Michelle A Ramos; Nicole R Kelly; Gabrielle Bertier; Christina Blackburn; Kaitlyn Brown; Lena Fielding; Jessenia Lopez; Karla Lopez Aguiniga; Estefany Maria; Jessica E Rodriguez; Monisha Sebastin; Nehama Teitelman; Dana Watnick; Nicole M Yelton; Avinash Abhyankar; Noura S Abul-Husn; Aaron Baum; Laurie J Bauman; Jules C Beal; Toby Bloom; Charlotte Cunningham-Rundles; George A Diaz; Siobhan Dolan; Bart S Ferket; Vaidehi Jobanputra; Patricia Kovatch; Thomas V McDonald; Patricia E McGoldrick; Rosamond Rhodes; Michael L Rinke; Mimsie Robinson; Arye Rubinstein; Lisa H Shulman; Christian Stolte; Steven M Wolf; Elissa Yozawitz; Randi E Zinberg; John M Greally; Bruce D Gelb; Carol R Horowitz; Melissa P Wasserstein; Eimear E Kenny
Journal:  Trials       Date:  2021-01-14       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.